At Amgen, we are dedicated to transforming new ideas and discoveries into medicines for patients with serious illnesses. On the ninth international Rare Disease Day, Amgen is proud to join the global effort and support this year's theme, "Patient Voice," to raise awareness and help make the voices of rare diseases heard.
In 2015, Amgen received approvals in both the U.S. and the EU that helped to bring therapies to patients living with rare diseases, including therapies for rare blood cancers and genetic disorders.
As a team in 2016, we at Amgen look forward to continuing to serve these patients while tirelessly working with researchers, healthcare professionals and advocacy groups to develop innovative therapies to treat individuals affected by the more than 6,500 rare diseases worldwide.1
For more information on Rare Disease Day, please visit www.rarediseaseday.org. To follow Amgen on Twitter, please visit www.twitter.com/amgen and join the conversation by tweeting your messages of support using #RareDiseaseDay.
- National Human Genome Research Institute. Frequently Asked Questions About Rare Diseases. http://www.genome.gov/27531963. Accessed Feb. 10, 2016.